CN Patent

CN112043835B — 用于含氮和羟基的药物的生物可逆引入基团

Assigned to Wuxi Hannopu Biotechnology Co ltd · Expires 2022-10-21 · 4y expired

What this patent protects

本公开是下式可用于含氮或羟基的药物或药物活性物质形成前药的引入基团： 和包含前药的药物组合物。

USPTO Abstract

本公开是下式可用于含氮或羟基的药物或药物活性物质形成前药的引入基团： 和包含前药的药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN112043835B
Jurisdiction
CN
Classification
—
Expires
2022-10-21
Drug substance claim
No
Drug product claim
No
Assignee
Wuxi Hannopu Biotechnology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.